Target
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
Ligand
BDBM50399407
Substrate
n/a
Meas. Tech.
ChEMBL_2271339
IC50
12±n/a nM
Citation
 Rana, PGhouse, SMAkunuri, RMadhavi, YVChopra, SNanduri, S FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors. Eur J Med Chem 208:0 (2020) [PubMed]
Target
Name:
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
Synonyms:
Enoyl-ACP Reductase (FabI) | Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | FABI_STAAR | NADPH-dependent enoyl-ACP reductase | fabI | trans-2-enoyl-[acyl carrier protein] reductase
Type:
Enzyme
Mol. Mass.:
27989.00
Organism:
Staphylococcus aureus
Description:
Q6GI75
Residue:
256
Sequence:
MLNLENKTYVIMGIANKRSIAFGVAKVLDQLGAKLVFTYRKERSRKELEKLLEQLNQPEAHLYQIDVQSDEEVINGFEQIGKDVGNIDGVYHSIAFANMEDLRGRFSETSREGFLLAQDISSYSLTIVAHEAKKLMPEGGSIVATTYLGGEFAVQNYNVMGVAKASLEANVKYLALDLGPDNIRVNAISAGPIRTLSAKGVGGFNTILKEIEERAPLKRNVDQVEVGKTAAYLLSDLSSGVTGENIHVDSGFHAIK
  
Inhibitor
Name:
BDBM50399407
Synonyms:
CHEMBL2178284 | MUT056399
Type:
Small organic molecule
Emp. Form.:
C15H13F2NO3
Mol. Mass.:
293.2654
SMILES:
CCc1cc(O)c(Oc2ccc(cc2F)C(N)=O)cc1F
Structure:
Search PDB for entries with ligand similarity: